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Abstract
Introduction: Non‑communicable diseases (NCDs) are major causes of morbidity and mortality particularly for developing 
countries. Large proportion of all NCDs deaths are occurring in low‑ and ‑middle‑income countries are estimated to occur 
in people under 70‑years‑old. These low‑ and middle‑income are undergoing epidemiological transition which allows 
the concomitant occurrence of both communicable and NCDs due to adoption of western life‑style that predisposes 
them to development of these diseases. It is also known that there are risk‑factors that tend to cluster in individuals and 
make them more susceptible to NCDs especially cardiovascular diseases (CVDs). Among NCDs, CVDs constitute the 
largest share responsible for 48% of all deaths due to NCDs. To determine extend of clustering of these risk‑factors in 
a semi‑urban community in northern Nigeria, a population‑based study was carried out.
Materials and Methods: This study was conducted in Dakace, a semi‑urban settlement near Zaria. A simple random 
sampling of 199 eligible respondents out of 424 was adopted to select study participants. An interviewer‑administered 
questionnaire was used to collect socio‑demographic information, smoking habits, alcohol consumption as well as level 
of physical activity. The following measurements were carried out on these respondents: Blood pressure (BP), fasting 
blood glucose, serum lipids, weight, and height to calculate body mass index (BMI).
Results: There were of 199 participants: 94 males (47.2%) and 105 females (52.8%) with an overall mean age of 
39.9 ± 15.6 years. About 20% had no risk factor; more females than males had risk‑factors. Proportion of subjects 
with risk‑factors increase with increasing BMI, particularly high BP; physical activity does not protect subjects from 
developing risk‑factors.
Conclusion: This study clearly shows that CVD risk‑factors are prevalent even in segment of the population that 
hitherto may be considered free and the prevalence of these risk‑factors are high compared to some obtained from 
other part of Nigeria.
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Diseases of the heart and circulation ‑ cardiovascular 
diseases (CVDs) ‑ are for most adults the risks to life.[1] The 
important CVD with high‑morbidity and mortality include 
coronary heart disease, stroke, hypertensive heart disease, 
and peripheral vascular disease.[1] They are increasingly 
becoming the major causes of morbidity and mortality 
in several developing countries.[1] In 1996, the burdens 
of CVDs are highlighted by the estimates provide by the 
Global Burden of Disease Study[2] and in the World Health 
Report 1999,[3] which indicated that of the 31.7 million 
deaths due to non‑communicable diseases (NCDs) 
16.7 million (50%) are attributed to CVDs; and more than 
one‑third of these deaths occur in middle aged adults.[4] 
Furthermore, it was estimated that 30.9% of all deaths in 
1998, as well as 10.3% of total disease‑related burden in 
terms of disability‑adjusted life years loss were attributed 
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to CVDs.[3] In developed countries, while heart diseases 
and stroke, which are their first and second leading causes 
of death for adult men and women are in the decline, 
hypertensive heart diseases and stroke in the developing 
countries are the emerging first and second leading causes 
of death.[5] One enthusiast has even stated that “in fact, 
CVD is already the leading cause of death not only in 
developed countries but, as of the mid‑1990s, in developing 
countries as well,”[6] a statement supported by data in the 
World Health Report 2003.[4]
In CVD, risk‑factor refers to attribute or characteristic 
that increases one’s chance of developing CVD. Identified 
risk‑factors for CVD have been classified into non‑modifiable 
risk‑factors such as age, sex, race/ethnicity, family history; 
and modifiable risk‑factors such as elevated low‑density 
lipoprotein (LDL) cholesterol, decreased high‑density 
lipoprotein (HDL) cholesterol, impaired glucose test, excess 
body fat (overweight and obesity). Modifiable behavioral 
risk‑factors are smoking, high dietary cholesterol, saturated 
fat, dietary salt, alcohol intake, and sedentary life‑style.[7] 
Four of these risk‑factors have been known to cluster in 
some individuals and have been identified as components 
of a syndrome called metabolic cardiovascular syndrome, 
or the “deadly quartet.”[8]
As part of larger study to assess the levels of cardiovascular 
risk‑factors among apparently healthy adults in a suburban 
area near Zaria in Northern Nigeria, clustering of these 




Dakace village is a small semi‑urban settlement located 
about 10 km along the new Zaria‑Jos highway. As it 
is the tradition in Hausaland, Dakace is divided into 
Angwa (or Ward or cluster of settlements that might be 
contiguous with one another or not), which is the smallest 
administrative unit headed by a Ward head. Dakace, with an 
estimated population of 4860,[9] is distinctly divided into two 
main settlements: (i) Dakace village and (ii) Mangu Dakace. 
Hausa people whose roots are from the ancient city of Zaria 
are the pre‑dominant inhabitants of Dakace village. Mangu 
Dakace is the newly developed area where the population 
is of diverse ethnic groups but, predominantly composes of 
the Mangus (from Jos‑Plateau) hence the name, Ikulus and 
Katafs (all from Kaduna State).
Sampling technique
Cluster sampling method was used to select respondents. 
Each of the eight Angwas that made up the study area 
was considered to be a cluster. Two Angwa from the 
original settlement (Kanawa and Ruga) and one Angwa 
from the newly developed area (Kataf) were selected 
using a simple random technique by balloting based 
on proportional distribution of the population between 
the two settlements. In each of the sampled Angwa, all 
eligible respondents were identified by a house‑to‑house 
enumeration and registered in a book. In all 492 eligible 
subjects were identified for the study. The identified 
eligible respondents were invited to participate in the 
study and at the end 424 participated. For reason of cost, 
199 subjects were selected using a systematic random 
sampling from the register of the eligible respondents 
already prepared. The systematic sampling employed 
every second eligible respondent on the register. This 
sub‑sample constituted the population on which lipids 
profile and blood glucose analyses were conducted.
Measurements
Following verbal informed consent the questionnaire 
was administered to sampled respondents, and blood 
pressure (BP), anthropometric measurements (height and 
weight), and venous blood taken in that order. Weight was 
measured to the nearest 0.5 kg using a portable electronic 
solar powered weighing scale Seca model (UNICEF); height 
was measured, to the nearest 0.5 cm without shoes using a 
wooden platform with gaze horizontal and a wooden meter 
rule placed against the wall. Those subjects with bony 
abnormality that could distort height measurement (and 
consequently body mass index [BMI]) were excluded from 
this part of the study but participated in all other aspect of 
the study, e.g., BP measurement, lipids profile tests.
Following administration of the questionnaire, each subject 
was asked to rest for about 5 min before the measurement 
of the BP. The BP was measured using mercury in bulb 
sphygmomanometer. The BP was measured in a sitting 
position using the dominant arm at the chest level and 
supported. Cuffs with adult bladder size (16 cm × 30 cm) 
were used. The measurements were taken to the nearest 
2 mmHg.[10]
Collection of venous blood
The sub‑sampled respondents for lipid and blood glucose 
analyses were asked to do an overnight fasting of at least 
14 h, after which, about 5 ml of venous blood was taken 
using a 5 ml disposable syringe and emptied into a 5 ml 
EDTA (Ethylene Diamine Triacetic Acid) bottle. All the 
collected venous blood samples were taken to the Chemical 
Pathology Department, ABUTH, serum separated within 
2 h of collection. The sera were stored at 2‑8°C. The samples 
were analyzed by a trained technologist, thereafter.
Serum glucose was estimated using enzymatic reaction by 
glucose oxidase and lipid profile tests (cholesterol, HDL, 
LDL and triglyceride) were carried out by methods described 
by the manufacturers of the test kits (BioSystem S.A. Costa 
Brava, 30, Barcelona, Spain).[11‑16]
Dahiru and Ejembi: Clustering of cardiovascular risk factors
513Nigerian Journal of Clinical Practice • Oct-Dec 2013 • Vol 16 • Issue 4
The cut‑off levels
The World Health Organization and the American National 
Cholesterol Education Program recommended blood lipid 
concentrations shown in Table 1 were used as reference 
cut‑off points. A systolic BP of 140 mmHg and/or a diastole 
of 90 mmHg were considered as hypertension. A BMI of 
between 25.00 and 29.99 was considered as overweight, 
and a BMI of  ≥ 30.00 was considered as obesity. [17,18] 
These cut‑off points were used to classify study participants 
accordingly.
Results
Total of 199 subjects participated in this part of the 
study [Table 2]. There were 94 males (47.2%) and 
105 females (52.8%); the overall mean of age was 
39.9 ± 15.6 years. Majority (70%) are within the age range 
of 25 and 64 years. For BMI, fasting blood glucose, serum 
total cholesterol, HDL cholesterol, LDL cholesterol and 
triglyceride the mean and 95% confidence intervals were 
39.9 years (95% CI: 37.8, 42.1), 22.57 kg/m2 (95% CI: 
21.70, 23.44), 133 mmHg (95% CI: 129, 136), 85 mmHg 
(95% CI: 83, 87), 3.97 mmol/L (95% CI: 3.714.21), 4.45 
mmol/L (95% CI: 4.27, 4.62), 1.03 mmol/L (95% CI: 
0.97, 1.08), 2.20 mmol/L (95% CI: 2.06, 2.34) and 0.82 
mmol/L (0.73, 0.91) respectively [Table 3]. Table 4 shows 
the prevalence of different risk factors: It ranged from as low 
as 0.5% (for elevated triglyceride) to 48.2% (decreased level 
of high density lipoprotein); for hypertension (diastole and 
or systole) was 31.2%. Figure 3 shows trend of prevalence 
of hypertension with increasing body mass index which 
increases linearly with increasing body mass index. Table 5 
gives the prevalence of risk factors; 33.2% had at least one 
risk factor while about 20% of the respondents were free of 
any risk factors. More females (85.6%) have clustering of 
risk factors compared to males (73.9%) as shown in Table 6 
which is a significant difference.
Discussion
Globally, NCDs are becoming major cause of morbidity 
and mortality particularly for developing countries.[19‑22] For 
the developing countries, it is estimated that by the year 
2020, 70% of deaths will be attributed to NCDs.[2] Of the 
estimated 57 million global deaths in 2008, 36 million (63%) 
were due to NCDs.[23,24] Further, in 2008, around 80% of 
the NCDs deaths (about 29 million) occurred in low and 
middle‑income countries. In addition, a higher proportion 
of (48%) of all NCDs deaths in low‑and‑middle‑income 
countries are estimated to occur in people under 70 years 
old – contrast to an estimated 26% in high‑income 
countries and a global average of 44%.[25] Nigeria, 
alongside other developing countries are undergoing 
epidemiological transition allowing concurrent presence 
of both communicable and NCDs. Thus, while major 
communicable diseases – malaria, tuberculosis, measles, 
HIV/AIDS, worm infestation – still persists, rapid increased 
Table 1: International classification of lipid profile
Classification TC (mmol/L) LDL (mmol/L) HDL (mmol/L) TG (mmol/L) Glucose (mmol/L)
Desirable <5.17 <3.36 >1.55 <2.26 <6.11
Borderline 5.17-6.18 3.36-4.11 0.91-1.53 2.26-4.50 6.11-6.94
High >6.21 >4.14 - >4.50 >6.94
Low - - <0.91 - -
HDL=High‑density lipoprotein, LDL=Low‑density lipoprotein, TG=Triglyceride, TC=Total cholesterol




















No formal education 74 37.2
Adult literacy class 7 3.5
Primary school 49 24.6
Secondary school 48 24.1









Category 1 (<2.50) 37 18.6
Category 2 (2.50-2.99) 62 31.2
Category 3 (3.00-3.49) 47 23.6
Category 4 (3.50-4.99) 53 26.6
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urbanization with concomitant rural‑urban migration, 
demographic, environmental, social, cultural and behavioral 
life‑style changes (sedentary life‑style, cigarette smoking, 
excessive alcohol, unhealthy dietary habits) might have 
led to rapid emergence of NCDs particularly CVDs.[26‑28]
Among NCDs, CVDs constitute the largest share. The largest 
proportion of NCDs deaths is caused by CVD, 48%.[25] The 
primary risk‑factors for CVD are hypertension, high‑cholesterol, 
diabetes, overweight/obesity, cigarette smoking and physical 
inactivity; hypertension, high‑cholesterol, diabetes and 
overweight have been known to cluster in some persons and 
identified as part of cardio metabolic syndrome.[29,30]
The current study was a population‑based survey in 
semi‑urban settlement in Northern Nigeria. It assessed the 
burden of CVD risk‑factors in this settlement. In respect, 
to presence of CVD risk‑factors, hypertension was found in 
31.2% of the subjects. This is similar to what was reported 
by Ulasi et al. in semi‑urban and rural communities in 
Enugu State, Southwestern Nigeria.[30] They reported a 
prevalence of hypertension of 32.8%, obesity of 17.3% and 
total cholesterol of 7.1%. Prevalence of obesity is much 
higher compared to the present study, however.
Working in South‑ western Nigeria, Oladapo et al.[31] 
documented prevalence of CVD risk‑ factors as: Hypertension 
20.8%, diabetes 2.5%, total cholesterol 3.2%; elevated LDL 
cholesterol 0.9%, triglyceride 1.9%, obesity 2.0%, smoking 
1.7%., physical inactivity 3.2%.[31] The results of these 
studies in South‑ Western and South‑ Eastern Nigeria show 
some fine variations in prevalence of CVD risk‑factors.
Clustering of CVD risk‑factors
In this study, modifiable cardiovascular risk‑factors in 
apparently healthy adults (15 years and above) were 
considered: Hypertension, obesity, elevated fasting 
blood glucose, elevated total cholesterol, elevated LDL 
cholesterol, reduced HDL cholesterol, elevated triglyceride, 
cigarette smoking, physical inactivity, and alcohol ingestion.
Overall, about 20% (or 1 in 5) adults in the study population 
was free of any of the risk factor investigated. As much as 
one third (33%) of the respondents have one risk factor and 
the percentage with at least one risk factor declined steadily 
to about 2% whom had at least 5 risk‑factors [Figure 1]. 
More females than males have the risk‑factors for CVD and 
the difference is significant (χ2 = 4.28, P = 0.039). In several 
studies, obesity seemed to play a central role in clustering 
of risk‑factors. For example, the study by Hoffman and 
Cubeddu[32] in apparently healthy Hispanics indicated that 
obese had higher prevalence of hypertension with 30%, low 
HDL cholesterol 58%, and elevated serum triglyceride 51% 
compared to the lean population. This study demonstrated 
that as BMI increases, cardiovascular risk‑factors also 
increases or tend to cluster (χ2 = 5.34, P = 0.148). Among 
those considered lean, 64.7% had at least a risk‑factor and 
the proportion with one or more risk factor increases steadily 
to 78.8% among normal, 86.6% among the overweight 
and to 92.8% of the obese [Figure 2]. Additionally, this 
study also demonstrated the pattern of increasing presence 
hypertension with increasing obesity [Figure 3]. Prevalence 
Table 6: Association between sex and presence of 
cardiovascular risk‑factors




Male (%) 23 (26.1) 65 (73.9) 88 (44.2)
Female (%) 16 (14.4) 95 (85.6) 111 (55.8)
Total 39 (19.6) 160 (80.4) 199 (100.0)
χ2=4.28, P=0.039, CVD=Cardiovascular disease
Table 3: Mean and standard deviation of some of the 
cardiovascular risk‑factors
Variable Mean SD
Age (years) 39.96 15.59
BMI (kg/m2) 23.41 4.31
Diastole (mmHg) 85.68 14.34
Systole (mmHg) 133.09 26.16
FBG (mmol/L) 3.96 1.79
Total cholesterol (mmol/L) 4.44 1.27
HDL cholesterol (mmol/L) 1.03 0.40
LDL cholesterol (mmol/L) 2.19 1.02
Triglyceride (mmol/L) 0.82 0.64
Physical activity level 3.00 0.69
BMI=Body mass index, FBG=Fasting blood glucose, HDL=High‑density 
lipoprotein, LDL=Low‑density lipoprotein
Table 4: Prevalence of cardiovascular risk factor




Elevated fasting blood glucose 3 1.5
Elevated total cholesterol 17 8.5
Elevated low-density lipoprotein 7 3.5
Decreased high-density lipoprotein 96 48.2
Elevated triglyceride 1 0.5
Current smoking 20 10.9
Alcohol ingestion 7 3.5
Physical inactivity 37 18.6
Table 5: Percent of people with at least one risk 
factor
Number of risk factor Number Percentage
One risk factor 66 33.16
Two risk-factors 37 18.59
Three risk-factors 29 14.57
Four risk-factors 10 5.03
Five risk-factors 4 2.01
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of hypertension increased from 22.3% among subjects with 
normal BMI to 97.8% among the obese subjects. Physical 
activity does not proffer protection against development 
of cardiovascular risk‑factors as seen in this study. Among 
those considered physically active (physical activity 
category 4), 3.8% were lean, 69.8% had normal BMI, 26.4% 
were overweight while none of the subjects was obese. 
This trend is significant (χ2 = 17.32, P = 0.044). In all the 
levels of physical activity categories (i.e., categories 1‑4) 
more people had risk‑factors compared to those without; at 
physical activity level 4, 66% of the subjects had at least one 
risk‑factor compared to 34% who had none. This is results 
is significant (χ2 = 9.967, P = 0.019) and might be due to 
small sample size involved in the study. Thus, large‑scale 
study is required to validate this result.
Conclusion
This study clearly shows that CVD risk‑factors are prevalent 
even in segment of the population that hitherto may be 
considered free and the prevalence of these risk‑factors are high 
compared to some obtained from other parts of Nigeria. There 
is clustering of these risk‑factors among the study participants 
in which only about 20% are free from these risk‑factors.
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